(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COBALT BIOLOGICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

COBALT BIOLOGICS

ST13

US500000087857201

Class

1

Filing

87857201

Registration

6283523

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

03/03/2026

Trademark type

Word

Nice classes

1

Filing date

03/30/2018

Registration date

03/02/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/02/2021

Last transaction

03/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/30/2020

First use in commerce

11/30/2020

Drawing code

4

Owner type

03

Owner location

Redmond, WA, US

Examiner

FOSS, KATHERINE M

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Cobalt Biologics, Inc.

Representatives

Abraham Lichy The Lichy Law Firm, P.C.

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagents for scientific and research use in the nature of antibodies

Publications

History of USPTO decisions and trademark events.

40 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/02/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/02/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/27/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/26/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/05/2021

IUAF

USE AMENDMENT FILED

12/24/2020

EISU

TEAS STATEMENT OF USE RECEIVED

12/24/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/21/2020

EX2G

SOU EXTENSION 2 GRANTED

08/20/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/20/2020

NREV

NOTICE OF REVIVAL - E-MAILED

07/09/2020

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

07/08/2020

PETG

PETITION TO REVIVE-GRANTED

07/08/2020

PROA

TEAS PETITION TO REVIVE RECEIVED

07/08/2020

EXT2

SOU EXTENSION 2 FILED

06/25/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/11/2019

EX1G

SOU EXTENSION 1 GRANTED

12/09/2019

EXT1

SOU EXTENSION 1 FILED

12/09/2019

EEXT

SOU TEAS EXTENSION RECEIVED

12/09/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/25/2019

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

04/14/2019

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

12/05/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/04/2018

PUBO

PUBLISHED FOR OPPOSITION

12/04/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/14/2018

ALIE

ASSIGNED TO LIE

10/27/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/15/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

09/26/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/26/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

09/26/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/26/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/07/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/07/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/07/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/25/2018

GNRT

NON-FINAL ACTION E-MAILED

07/25/2018

CNRT

NON-FINAL ACTION WRITTEN

07/25/2018

DOCK

ASSIGNED TO EXAMINER

07/17/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/07/2018

NWAP

NEW APPLICATION ENTERED

04/03/2018

Continuous trademark protection

Get notified about every new filing that threatens COBALT BIOLOGICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.